New York 2025 Session Status: Enacted

A5285 — Relates to prescription labels for mifepristone and misoprostol

Last action — Signed by Governor

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Assembly
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced February 12, 2025. Enacted.

Signed by Governor Kathy Hochul (Democratic) on March 20, 2025.

Prognosis

Advancing 50% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

Bill Text

Action History

  1. SIGNED CHAP.108

  2. DELIVERED TO GOVERNOR

  3. RETURNED TO ASSEMBLY

  4. PASSED SENATE

  5. 3RD READING CAL.447

  6. SUBSTITUTED FOR S4587

  7. REFERRED TO RULES

  8. DELIVERED TO SENATE

  9. PASSED ASSEMBLY

  10. ORDERED TO THIRD READING RULES CAL.103

  11. RULES REPORT CAL.103

  12. REPORTED

  13. REPORTED REFERRED TO RULES

  14. REFERRED TO HIGHER EDUCATION

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does A5285 do?
Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.
Who sponsors A5285?
A5285 is sponsored by Karines Reyes.
What is the current status of A5285?
This bill has been enacted into law. Introduced February 12, 2025. Enacted.
Where can I track A5285?
Track A5285 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on A5285

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of A5285

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →